Protalix Biotherapeutics Inc (NYSE American:PLX)

Delayed Data
As of 2:19pm ET
 +0.0009 / +0.28%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 2.05, with a high estimate of 3.00 and a low estimate of 1.10. The median estimate represents a +544.45% increase from the last price of 0.32.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Protalix Biotherapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -25.00%
Growthannually 19.44%


Growthquarterly -9.81%
Growthannually 456.30%
Key to the earnings and sales forecast charts.